Опыт Организации Системы Здравоохранения Великобритании По Фармацевтическому Обеспечению Лекарствами Льготных Категорий Населения

Abstract

Background. Health is the highest value not only in the context of the perception of a person, but also society and the state as a whole. According to the content of international documents approved by the UN General Assembly, the WHO, the World Medical Association, governments should be responsible for the health of the population, ensure the implementation of the human right to life and health. Previously, the state of affairs in Ukraine regarding the pharmaceutical provision of privileged categories of citizens was studied. However, for forming a powerful and effective health care system in Ukraine for the pharmaceutical provision of privileged categories of citizens, it is useful to analyze the experience of providing health care in economically developed countries. The purpose of the research was to study the Great Britain experience with the organization of a healthcare system for the pharmaceutical provision of medicines to privileged population groups. Materials and methods. Common methods of normative legal, documentary, retrospective and comparative analysis used to gain that purpose. Results. The system of financing health care in the Great Britain provides getting finances mainly from the state budget, while the division takes place on the management vertical from the highest level to the lower one. The taxes that make up about 90% of the health care system budget are the financial basis of the national health system of the Great Britain. For comparison, only 7.5% comes from employers. Therefore, can argue that the healthcare system of the Great Britain in fact completely financed by financial contributions from taxpayers and by the government. There are three main models of financing health care allocated in the world practice: private, budget (model Beveridge), mixed (Bismarck model). A private financing model exists through the creation of sustainable competition between healthcare facilities. The part of private insurance is about 40% of total costs, and the patient himself covers the cost of pharmaceutical provision. A private financing model is typical for such developed countries as the United States of America and Japan. The budget model of funding or the Beveridge model means covering a large part of the costs of pharmaceutical provision by state institutions. This model is also typical for Great Britain. A mixed financing model or Bismarck model based on the three foundations: the state, enterprises and personal funds of a citizen. This system of insurance financing is typical for Germany, Austria and France. Private medicine in the Great Britain is one of the most advanced and most expensive in the world. There are about 300 non-state hospitals in the country, that receive a license at a local the National Health Service unit and tested twice a year. There are no queues here and medical care provided in full and to the extent necessary. The services of pay-doctors and cabinets paid either by insurance companies or by patients themselves. Large companies in Britain have health insurance as a...

Pharmacotherapy of Systemic Vasculitis Combined with Cryoglobulinemic Syndrome Using Pharmacoeconomic Approaches

“…Previously, the experience of the USA concerning and organization of healthcare system for the pharmaceutical provision for privileged categories of citizens was written (Shapovalov (Jr.) et al, 2019); forensic and pharmaceutical analysis of addictive morbidity because of the use of psychoactive substances in Ukraine ; experience of Great Britain in the organization of healthcare system for pharmaceutical provision with medicines for privileged categories of citizens (Shapovalov (Jr.) et al, 2019).…”

Pharmacological View on the Problem of Comorbidity in the Pharmacotherapy of Chronic Pancreatitis

“…The information base of the study consisted of scientific works of foreign and domestic scientists on issues related to the clinical pharmacy, organization of pharmaceutical business, management, forensic pharmacy, pharmaceutical supply, pricing policy for drugs [10][11][12][13].…”

Forensic Pharmacy: Analysis of Complaints About the Pharmaceutical Provision for Privileged Categories of Patients in Ukraine (Experimental Research)

“…In addition, at various times, a system of "preferential prescriptions", pilot projects to reimburse the cost of drugs, health insurance funds were introduced into practice. The ideas of insurance medicine have been actively discussed for a long time, but without any real steps for its implementation [3,4].…”

“…Disadvantages of the state system of pharmaceutical provision of privileged contingents of patients in Ukraine include overstated costs for the purchase of drugs due to corruption schemes, lack of market pricing, a huge number of formal requirements for tender documents, lack of long-term procurement planning by the state for manufacturing companies [5,6].…”